Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes

Objective To compare the effect of two strategies of antibiotic use (mixing vs. cycling) on the acquisition of resistant microorganisms, infections and other clinical outcomes. Methods Prospective cohort study in an 8-bed intensive care unit during 35- months in which a mixing-cycling policy of antipseudomonal beta-lactams (meropenem, ceftazidime/piperacillin-tazobactam) and fluoroquinolones was operative. Nasopharyngeal and rectal swabs and respiratory secretions were obtained within 48h of admission and thrice weekly thereafter. Target microorganisms included methicillin-resistant S. aureus, vancomycin-resistant enterococci, third-generation cephalosporin-resistant Enterobacteriaceae and non-fermenters. Results A total of 409 (42%) patients were included in mixing and 560 (58%) in cycling. Exposure to ceftazidime/piperacillin-tazobactam and fluoroquinolones was significantly higher in mixing while exposure to meropenem was higher in cycling, although overall use of antipseudomonals was not significantly different (37.5/100 patient-days vs. 38.1/100 patient-days). There was a barely higher acquisition rate of microorganisms during mixing, but this difference lost its significance when the cases due to an exogenous Burkholderia cepacia outbreak were excluded (19.3% vs. 15.4%, OR 0.8, CI 0.5–1.1). Acquisition of Pseudomonas aeruginosa resistant to the intervention antibiotics or with multiple-drug resistance was similar. There were no significant differences between mixing and cycling in the proportion of patients acquiring any infection (16.6% vs. 14.5%, OR 0.9, CI 0.6–1.2), any infection due to target microorganisms (5.9% vs. 5.2%, OR 0.9, CI 0.5–1.5), length of stay (median 5 d for both groups) or mortality (13.9 vs. 14.3%, OR 1.03, CI 0.7–1.3). Conclusions A cycling strategy of antibiotic use with a 6-week cycle duration is similar to mixing in terms of acquisition of resistant microorganisms, infections, length of stay and mortality.

[1]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[2]  M. Bonten,et al.  Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial , 2014, Trials.

[3]  Sebastian Bonhoeffer,et al.  Cycling Empirical Antibiotic Therapy in Hospitals: Meta-Analysis and Models , 2014, PLoS pathogens.

[4]  K. Akashi,et al.  Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity , 2013, PloS one.

[5]  D. Anderson,et al.  A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. , 2012, The Journal of surgical research.

[6]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  C. Castillo-Chavez,et al.  Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals , 2011, Journal of biological dynamics.

[8]  P. Wayne.  CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .

[9]  I. Gould,et al.  Antibiotic heterogeneity: from concept to practice , 2010, Annals of the New York Academy of Sciences.

[10]  Hiroki Ikeuchi,et al.  Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. , 2010, The Journal of hospital infection.

[11]  M. Bonten,et al.  Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria , 2009, Intensive Care Medicine.

[12]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  H. Evans,et al.  Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. , 2008, Surgical infections.

[14]  H. Evans,et al.  Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. , 2008, Surgical infections.

[15]  K. Kaye,et al.  Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. , 2007, The Journal of trauma.

[16]  J. Ma,et al.  Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit , 2007, Bone Marrow Transplantation.

[17]  J. Rello,et al.  Impact of diversity of antibiotic use on the development of antimicrobial resistance. , 2006, The Journal of antimicrobial chemotherapy.

[18]  C. Codina,et al.  Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units* , 2006, Critical care medicine.

[19]  H. Evans,et al.  Nature of gram-negative rod antibiotic resistance during antibiotic rotation. , 2005, Surgical infections.

[20]  J. Magee.  The resistance ratchet: theoretical implications of cyclic selection pressure. , 2005, The Journal of antimicrobial chemotherapy.

[21]  A. Troelstra,et al.  Antibiotic rotation and development of gram-negative antibiotic resistance. , 2005, American journal of respiratory and critical care medicine.

[22]  D. Ledoux,et al.  Selection of resistance during sequential use of preferential antibiotic classes , 2005, Intensive Care Medicine.

[23]  M. Kollef,et al.  Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients , 2004, Critical care medicine.

[24]  Carl T. Bergstrom,et al.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Gruson,et al.  Strategy of antibiotic rotation: Long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia* , 2003, Critical care medicine.

[26]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[27]  B. Allegranzi,et al.  Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. , 2002, The Journal of hospital infection.

[28]  M. Walsh,et al.  The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. , 2002, Pediatrics.

[29]  Michael A. Veltri,et al.  Pilot study of antibiotic cycling in a pediatric intensive care unit , 2002, Critical care medicine.

[30]  B. Levin,et al.  Minimizing potential resistance: a population dynamics view. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  T. Crabtree,et al.  Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit , 2001, Critical care medicine.

[32]  D. Gruson,et al.  Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. , 2000, American journal of respiratory and critical care medicine.

[33]  A. Torres,et al.  Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. , 2000, American journal of respiratory and critical care medicine.

[34]  Carl T. Bergstrom,et al.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Anderson,et al.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Gerding,et al.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.

[38]  L. Peterson,et al.  Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital , 1991, Antimicrobial Agents and Chemotherapy.

[39]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[40]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[41]  J. Mcgowan,et al.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use. , 1983, Reviews of infectious diseases.